Actualités GW Pharmaceuticals PLC - GWPH | Actions NASDAQ

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A...

Current Report Filing (8-k)

CB24 9BZ United Kingdom 00-0000000 false 0001351288 0001351288 2021-04-14 2021-04-14 UNITED...

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) ...

EPIDOLEX encore presentations highlight long-term safety and efficacy data in patients with tuberous sclerosis...

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

BENZINGA (PAOG) - Catalyst From PAO Group Inc.'s CBD-Based Therapeutics Program In Play; Accelerates RespRx R&D Program

March 24, 2021 -- InvestorsHub NewsWire -- via Benzinga -- Are you looking to learn how to actually properly analyze stocks...

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Current Report Filing (8-k)

00-0000000 266800 false 0001351288 0001351288 2021-03-22 2021-03-22 UNITED STATES SECURITIES AND...

PAOG Undervalued With CBD Nutraceutical Partnerships

Here’s Why PAO Group Inc. Stock Looks Tremendously Undervalued; Dividend And CBD-Based Nutraceuticals Partnerships Are Two...

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Proxy Statement - Merger or Acquistion (definitive) (defm14a)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION...

Schedule 13g

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of...

Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Annual Report (10-k)

false FY 0001351288 --12-31 00-0000000 true true true true P5Y P6Y6M P6Y6M us-gaap:OtherLiabilitiesCurrent us-gaap:OtherLiabilitie...

GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX® (cannabidiol) for use as treatment of seizures associated w...

LONDON, Feb. 26, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

GW Pharmaceuticals PLC (GWPH)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

GWPH Actualités

Additional Proxy Soliciting Materials (definitive) (defa14a)

Current Report Filing (8-k)

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) ...

Additional Proxy Soliciting Materials (definitive) (defa14a)

BENZINGA (PAOG) - Catalyst From PAO Group Inc.'s CBD-Based Therapeutics Program In Play; Accelerates RespRx R&D Program

Additional Proxy Soliciting Materials (definitive) (defa14a)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Current Report Filing (8-k)

PAOG Undervalued With CBD Nutraceutical Partnerships

Additional Proxy Soliciting Materials (definitive) (defa14a)

Proxy Statement - Merger or Acquistion (definitive) (defm14a)

Schedule 13g

Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)

Annual Report (10-k)

GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX® (cannabidiol) for use as treatment of seizures associated w...

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

GW Pharmaceuticals PLC (GWPH) Actualités

GW Pharmaceuticals PLC (GWPH)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

GWPH Actualités

Additional Proxy Soliciting Materials (definitive) (defa14a)

Current Report Filing (8-k)

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) ...

Additional Proxy Soliciting Materials (definitive) (defa14a)

BENZINGA (PAOG) - Catalyst From PAO Group Inc.'s CBD-Based Therapeutics Program In Play; Accelerates RespRx R&D Program

Additional Proxy Soliciting Materials (definitive) (defa14a)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Current Report Filing (8-k)

PAOG Undervalued With CBD Nutraceutical Partnerships

Additional Proxy Soliciting Materials (definitive) (defa14a)

Proxy Statement - Merger or Acquistion (definitive) (defm14a)

Schedule 13g

Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)

Annual Report (10-k)

GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX® (cannabidiol) for use as treatment of seizures associated w...

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application